Navidea posts mixed Q3 2018 results

Radiopharmaceutical developer Navidea Biopharmaceuticals has posted mixed results...Read more on AuntMinnie.comRelated Reading:
Suit against Navidea dismissed
Navidea receives acceptance letter from NYSE American
Navidea enters NIH CAP program, raises $3M
NYSE American delivers noncompliance notice to Navidea
Navidea posts lower revenue in Q2 2018

Source: AuntMinnie.com Headlines - November 8, 2018 Category: Radiology Source Type: news